Log on / register
Feedback | Support | My details
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients.
Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L
Crit Care 2003 Oct, 7:R78-83
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.
Thiolas A, Bollet C, La Scola B, Raoult D, Pagès JM
Antimicrob Agents Chemother 2005 Apr, 49:1354-8
[PubMed Central] [PubMed] [Related articles]

2.
Metallo-beta-lactamases: the quiet before the storm?
Walsh TR, Toleman MA, Poirel L, Nordmann P
Clin Microbiol Rev 2005 Apr, 18:306-25
[PubMed Central] [PubMed] [Related articles]

3.
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.
Tam VH, Schilling AN, Vo G, Kabbara S, Kwa AL, Wiederhold NP, Lewis RE
Antimicrob Agents Chemother 2005 Sep, 49:3624-30
[PubMed Central] [PubMed] [Related articles]

4.
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME
Antimicrob Agents Chemother 2005 Aug, 49:3136-46
[PubMed Central] [PubMed] [Related articles]

5.
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.
Li J, Rayner CR, Nation RL, Deans R, Boots R, Widdecombe N, Douglas A, Lipman J
Antimicrob Agents Chemother 2005 Nov, 49:4814-5
[PubMed Central] [PubMed] [Related articles]

6.
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.
Bergen PJ, Li J, Rayner CR, Nation RL
Antimicrob Agents Chemother 2006 Jun, 50:1953-8
[PubMed Central] [PubMed] [Related articles]

7.
The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.
Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A
Clin Med Res 2006 Jun, 4:138-46
[PubMed Central] [PubMed] [Related articles]

8.
Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.
Coelho JM, Turton JF, Kaufmann ME, Glover J, Woodford N, Warner M, Palepou MF, Pike R, Pitt TL, Patel BC, Livermore DM
J Clin Microbiol 2006 Oct, 44:3623-7
[PubMed Central] [PubMed] [Related articles]

9.
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.
Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II
Antimicrob Agents Chemother 2007 Jun, 51:1905-11
[PubMed Central] [PubMed] [Related articles]

10.
Colistin: the phoenix arises.
Conly J, Johnston B
Can J Infect Dis Med Microbiol 2006 Sep, 17:267-9
[PubMed Central] [PubMed] [Related articles]

11.
Multidrug-resistant organisms in military wounds from Iraq and Afghanistan.
Calhoun JH, Murray CK, Manring MM
Clin Orthop Relat Res 2008 Jun, 466:1356-62
[PubMed Central] [PubMed] [Related articles]

12.
Polymyxins revisited.
Landman D, Georgescu C, Martin DA, Quale J
Clin Microbiol Rev 2008 Jul, 21:449-65
[PubMed Central] [PubMed] [Related articles]

13.
Acinetobacter baumannii: emergence of a successful pathogen.
Peleg AY, Seifert H, Paterson DL
Clin Microbiol Rev 2008 Jul, 21:538-82
[PubMed Central] [PubMed] [Related articles]

14.
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.
Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B, Weiss K, Zhanel GG
Can J Infect Dis Med Microbiol 2008 Jan, 19:19-53
[PubMed Central] [PubMed] [Related articles]

15.
Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa.
Sabuda DM, Laupland K, Pitout J, Dalton B, Rabin H, Louie T, Conly J
Can J Infect Dis Med Microbiol 2008 Nov, 19:413-8
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 3 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.